Brief: HOOKIPA Pharma Q3 Net Income USD -19.066 Million
09/11/2023 12:01
Nov 09 (Reuters) - HOOKIPA Pharma Q3 revenue USD 6.867 million. * Q3 basic EPS USD -0.17 * Q3 operating income USD -22.67 million * Q3 operating expenses USD -29.537 million
Recent news on Hookipa Pharma
See all newsBrief: Hookipa Pharma Announces Sale Of Oncology Assets To Neotrail Therapeutics
Brief: Hookipa Pharma Announces Intention To Voluntarily Delist And Deregister Its Common Stock
Hookipa Pharma Inc Expected To Post A Loss Of $1.04 A Share: Earnings Preview
Brief: Poolbeg Pharma Says Hookipa Terminated Discussions On Proposed Merger
HOOKIPA Pharma Inc. (“HOOKIPA”) Statement regarding potential combination for Poolbeg Pharma plc (“Poolbeg”)